Home
  • Clinical Trials
  • Partnerships
  • Contact Us
  • News & Resources
  • Careers
  • About Us
    • Management Team
    • Board of Directors
    • Scientific and Clinical Advisory Boards
    • Commercial Advisory Board
  • Our Focus
    • Infectious Disease
    • Oncology
  • Our Product
  • Our Pipeline
    • Prophylactic
    • Therapeutic
    • Clinical Trials
    • Publications
    • Early/Expanded Access Policy
  • Our Science
  • Investors
    • Press Releases
    • Events and Presentations
    • Company Information
    • Stock Information
    • SEC Filings
    • Corporate Governance
  • About Us
    • Management Team
    • Board of Directors
    • Scientific and Clinical Advisory Boards
    • Commercial Advisory Board
  • Our Focus
    • Infectious Diseases
    • Oncology
  • Our Pipeline
    • Prophylactic
    • Therapeutic
    • Clinical Trials
    • Publications
    • Early/Expanded Access Policy
  • Our Product
  • Our Science and Technology
  • News and Resources
    • News
    • Posters
    • Publications
    • Videos
  • Investors
    • Press Releases
    • Company Information
    • Corporate Governance
    • Events and Presentations
    • SEC Filings
    • Stock Information
  • Careers
  • Partnerships
  • Contact Us
Search our website

Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S Vaccine

February 8, 2021 | Publications

View More

March 13, 2023

VBI Vaccines Reports Full Year 2022 Financial Results

February 23, 2023

VBI Vaccines to Discuss Progress in Hepatitis B Portfolio in Analyst-Led Fireside Chat

February 15, 2023

VBI Vaccines Announces Presentation of Interim Phase 2 Data Evaluating Combination of VBI-2601 (BRII-179) and BRII-835 for the Treatment of Chronic Hepatitis B

December 8, 2022

VBI Vaccines Announces Health Canada Approval for PreHevbrio™ for the Prevention of Hepatitis B in Adults

Sign-up for Our Distribution List to Receive the Latest News and Updates from VBI

Sign Up NowArrow
Go top
Navigate
  • About Us
  • Our Focus
  • Our Science and Technology
  • Our Pipeline
  • Investors
  • Clinical Trials
  • Contact Us
About Us
  • Management Team
  • Board of Directors
  • Scientific and Clinical Advisory Boards
  • Commercial Advisory Board
  • Partnerships
  • News and Resources
  • Careers
Connect With Us
  • Twitter Icon
  • Facebook Icon
  • YouTube Icon
  • LinkedIn Icon
VBI Logo Home

© 2023 VBI Vaccines Inc. All rights reserved.

  • Privacy Policy
  • Cookies Policy
  • Terms of Use
  • Site Map
  • Contact Us